Literature DB >> 10234516

Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions.

L R Desviat1, B Pérez, A Gámez, A Sánchez, M J García, M Martínez-Pardo, C Marchante, D Bóveda, A Baldellou, J Arena, P Sanjurjo, A Fernández, M L Cabello, M Ugarte.   

Abstract

We present an extensive study of the genetic diversity of phenylalanine hydroxylase deficiency in the Spanish phenylketonuria population. We have analysed 195 PKU patients by DGGE analysis identifying 67 different mutations which represent 89% of the total mutant chromosomes. Seventeen mutations first described in Spain have not yet been detected elsewhere; ten of these are reported here for the first time. The clinical significance of this high genetic heterogeneity was examined by analysing the genotype-phenotype correlations, mainly focusing on the mild hyperphenylalaninaemia (MHP) phenotype. The genotypes found in a group of 93 MHP patients, the largest analysed so far, are described in detail, as well as the relative frequencies of the MHP mutations identified. From the total pool of mutations, 27 can be considered severe, 18 can be defined as mild and 13 as associated with MHP. The prevalent mutations correspond to one severe mutation (IVS10nt-11), one MHP mutation (A403V) and two mild mutations (165T and V388M). The high frequency of mutations with a low degree of severity can explain the relatively higher prevalence of MHP and mild PKU phenotypes in Spain compared with NOrthern European populations. We have looked at the geographical distribution in Spain of the more common mutations, finding evidence of local mutation clustering, which could be the result of differences in the ethnic background and/or of genetic drift within each region.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10234516     DOI: 10.1038/sj.ejhg.5200312

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

1.  Protein stability and in vivo concentration of missense mutations in phenylalanine hydroxylase.

Authors:  Zhen Shi; Jenn Sellers; John Moult
Journal:  Proteins       Date:  2011-09-21

2.  The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutations.

Authors:  B Pérez; P Briones; D Quelhas; R Artuch; A I Vega; E Quintana; L Gort; M J Ecay; G Matthijs; M Ugarte; C Pérez-Cerdá
Journal:  JIMD Rep       Date:  2011-06-22

3.  Mutational spectrum of classical galactosaemia in Spain and Portugal.

Authors:  L Gort; M D Boleda; L Tyfield; L Vilarinho; I Rivera; M L Cardoso; M Santos-Leite; M Girós; P Briones
Journal:  J Inherit Metab Dis       Date:  2006-10-14       Impact factor: 4.982

4.  Computational study of missense mutations in phenylalanine hydroxylase.

Authors:  Kamila Réblová; Petr Kulhánek; Lenka Fajkusová
Journal:  J Mol Model       Date:  2015-03-07       Impact factor: 1.810

5.  Molecular characterization of Thai patients with phenylalanine hydroxylase deficiency and in vitro functional study of two novel PAH variants.

Authors:  Lukana Ngiwsara; Nithiwat Vatanavicharn; Phannee Sawangareetrakul; Somporn Liammongkolkul; Pisanu Ratanarak; Boonchai Boonyawat; Chantragan Srisomsap; Voraratt Champattanachai; James Ketudat-Cairns; Pornswan Wasant; Jisnuson Svasti
Journal:  Mol Biol Rep       Date:  2021-03-07       Impact factor: 2.316

Review 6.  What we know that could influence future treatment of phenylketonuria.

Authors:  C N Sarkissian; A Gámez; C R Scriver
Journal:  J Inherit Metab Dis       Date:  2008-08-03       Impact factor: 4.982

7.  Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases.

Authors:  Angel L Pey; Francois Stricher; Luis Serrano; Aurora Martinez
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

8.  Molecular epidemiology, genotype-phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria.

Authors:  Luis Aldámiz-Echevarría; Marta Llarena; María A Bueno; Jaime Dalmau; Isidro Vitoria; Ana Fernández-Marmiesse; Fernando Andrade; Javier Blasco; Carlos Alcalde; David Gil; María C García; Domingo González-Lamuño; Mónica Ruiz; María A Ruiz; Luis Peña-Quintana; David González; Felix Sánchez-Valverde; Lourdes R Desviat; Belen Pérez; María L Couce
Journal:  J Hum Genet       Date:  2016-04-28       Impact factor: 3.172

9.  Quality of diagnostic mutation analyses for phenylketonuria.

Authors:  J Zschocke; C Aulehla-Scholz; S Patton
Journal:  J Inherit Metab Dis       Date:  2008-11-21       Impact factor: 4.982

10.  Spectrum of PAH gene mutations in 1547 phenylketonuria patients from Iran: a comprehensive systematic review.

Authors:  Reza Alibakhshi; Aboozar Mohammadi; Nader Salari; Sahand Khamooshian; Mohsen Kazeminia; Keivan Moradi
Journal:  Metab Brain Dis       Date:  2021-02-24       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.